跳至主要内容
临床试验/IRCT20230526058298N1
IRCT20230526058298N1尚未招募1 期

Comparison of Efficacy of Aripiprazole versus Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment of Resistant Obsessive Compulsive Disorder: A Randomized Controlled Trial

Postgraduate Medical Institute Lahore0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • ?Patients of age 16-65 years of either gender
  • ?Patients diagnosed with obsessive compulsive disorder (as per operational definition) with Y-BOCS score =16.

排除标准

  • ?Pregnant females
  • ?Patient allergic to trial drugs
  • ?Patient having an organic cause for their symptoms
  • ?Patient with comorbid conditions that aggravate the condition or develop depression and anxiety

研究者

发起方
Postgraduate Medical Institute Lahore

相似试验